Key result
Elevated platelet-to-lymphocyte ratio is linked to ~1% higher in-hospital mortality.
Why the study?
Fulminant myocarditis supported by VA-ECMO carries a very high mortality rate, and outcome prediction remains difficult due to severe hemodynamic collapse and disease-intrinsic thrombo-inflammation. This study evaluated the prognostic value of inflammatory indices and developed a nomogram for early risk stratification.
Does a prognostic nomogram incorporating the platelet-to-lymphocyte ratio (PLR) and baseline clinical severity markers at ECMO initiation predict all-cause in-hospital mortality in patients with fulminant myocarditis supported by VA-ECMO?
Cohort (n=118)
No
Does a prognostic nomogram incorporating the platelet-to-lymphocyte ratio (PLR) and baseline clinical severity markers at ECMO initiation predict all-cause in-hospital mortality in patients with fulminant myocarditis supported by VA-ECMO?
In patients with fulminant myocarditis supported by VA-ECMO, an exploratory five-variable nomogram incorporating the platelet-to-lymphocyte ratio, SOFA score, LVEF, lactate, and LDH at ECMO initiation discriminated in-hospital mortality with an optimism-corrected AUC of 0.887.
Answers are grounded in this paper and cite their sources.
PLR nomogram may aid early mortality risk stratification in VA-ECMO-supported fulminant myocarditis; hypothesis-generating and requires prospective validation.
Background Fulminant myocarditis (FM) supported by venoarterial extracorporeal membrane oxygenation (VA-ECMO) carries a very high mortality rate, and outcome prediction remains difficult because patients face both severe hemodynamic collapse and disease-intrinsic thrombo-inflammation. This study evaluated the prognostic value of several inflammatory indices and developed a nomogram for early risk stratification in this population. Methods This retrospective cohort study included 118 consecutive patients with FM receiving VA-ECMO. All predictors were ascertained at a single pre-specified time point: ECMO initiation (T0). Variables were selected using the Least Absolute Shrinkage and Selection Operator (LASSO) regression. Multivariable logistic regression was used to evaluate three inflammatory markers: the platelet-to-lymphocyte ratio (PLR), the neutrophil-to-lymphocyte ratio (NLR), and systemic immune-inflammation index (SII). A nomogram was constructed and assessed using receiver operating characteristic (ROC) curves, calibration plots, and decision curve analysis (DCA). Results In-hospital mortality was 33.9%. LASSO selected four clinical covariates (SOFA score, left ventricular ejection fraction (LVEF), baseline lactate and LDH), which together with the index marker PLR formed a five-variable model. Non-survivors had lower PLR than survivors in the group comparison, which may reflect shock-related consumptive coagulopathy; however, this direction was not confirmed when PLR was modelled as a continuous covariate, and after adjustment for baseline severity elevated PLR was independently associated with mortality (OR = 1.006 per unit increment, 95% CI: 1.002–1.010; P = 0.008). NLR and SII were not statistically significant in the multivariable models. The PLR-based nomogram achieved an optimism-corrected AUC of 0.887, with calibration and decision curve analyses showing acceptable agreement; the model requires external validation before any clinical use. Conclusions A nomogram combining PLR, SOFA score, LVEF, baseline lactate, and LDH discriminated in-hospital mortality in this cohort with an optimism-corrected AUC of 0.887. PLR was the only inflammatory index independently associated with mortality after adjustment, whereas discrimination did not differ significantly among the PLR, NLR and SII models. These findings may reflect the specific role of platelet-lymphocyte interactions in the thrombo-inflammatory process of fulminant myocarditis, and they require external validation. The model should be regarded as exploratory, and external validation is required before any clinical use.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) conducted a cohort in Fulminant myocarditis supported by venoarterial extracorporeal membrane oxygenation (VA-ECMO) (n=118). Platelet-to-lymphocyte ratio (PLR) at ECMO initiation vs. Per unit increment in PLR (continuous variable) and comparison with NLR and SII was evaluated on All-cause in-hospital mortality (OR 1.006, 95% CI 1.002-1.010, p=0.008). Elevated platelet-to-lymphocyte ratio independently predicted in-hospital mortality, and a 5-variable PLR nomogram achieved an optimism-corrected AUC of 0.887.
Synapse has enriched 10 related papers. Consider them for comparative context: